Novel oral anticoagulants for the secondary prevention of cerebral ischemia: a network meta-analysis. - Wikidata - wikimedia - TriplyDB

Novel oral anticoagulants for the secondary prevention of cerebral ischemia: a network meta-analysis.

Novel oral anticoagulants for the secondary prevention of cerebral ischemia: a network meta-analysis.

http://www.wikidata.org/entity/Q37197199

about

Under-representation of women in stroke randomized controlled trials: inadvertent selection bias leading to suboptimal conclusions.Recent Advances in Primary and Secondary Prevention of Atherosclerotic Stroke.

P2860

Q33663081-F82AD2BD-6237-4915-8A9F-1D3C8C84B04F Q55317625-8736FD0D-3B49-4A06-BA78-BDDABCCEF04F

P2860

Novel oral anticoagulants for the secondary prevention of cerebral ischemia: a network meta-analysis.

http://www.wikidata.org/entity/Q37197199

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 20 July 2016

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Novel oral anticoagulants for ...... emia: a network meta-analysis.

@en

Novel oral anticoagulants for ...... emia: a network meta-analysis.

@nl

type

label

Novel oral anticoagulants for ...... emia: a network meta-analysis.

@en

Novel oral anticoagulants for ...... emia: a network meta-analysis.

@nl

prefLabel

Novel oral anticoagulants for ...... emia: a network meta-analysis.

@en

Novel oral anticoagulants for ...... emia: a network meta-analysis.

@nl

P1433

Q37197199-51113F07-EB71-4A95-8F65-ACD953A2A1DA

P1476

Q37197199-77B94336-2CF8-440F-B6F7-6AD3B4C8D6E4

P2093

Q37197199-0DB3021A-3DC4-4FC1-BDE2-264BB70C0758

Q37197199-141FCC23-A6BB-4B56-B016-B6266C3E5AFB

Q37197199-149A1BF3-E1BE-4D2C-BBD5-47BA5ED6E4B1

Q37197199-313E32E7-E54B-47A4-8139-C91733291377

Q37197199-37DB6123-6F13-4A8A-AE35-1DA8C102DF4F

Q37197199-47DD3C28-88AC-4235-B90E-9A7ECE119455

Q37197199-61962FD5-8C12-453E-939D-2266CB8FC133

Q37197199-69166673-5584-4207-8605-E1416A9396BA

Q37197199-8B0E810A-4EE0-4416-B78F-E45BD8AA4A36

Q37197199-AC03BF2F-F043-446C-B0FD-B469C60477B4

P2860

Q37197199-0B57894C-1B3E-45F9-8295-FE026F901D61

Q37197199-167ABDC9-F02A-488C-B761-F0D8B218A210

Q37197199-1DF50CF5-C89F-431E-B198-8146F83C987E

Q37197199-24D563A2-B0CB-4740-B134-3D05CC0E18F0

Q37197199-26ACC608-FF17-4DE7-AC81-2EA41B15447A

Q37197199-31EF2E94-FCB4-4E21-9920-67E15D93FD6D

Q37197199-3292F441-BEFD-4077-9834-62FFC2DAE0FB

Q37197199-3F56815A-F411-403D-847F-D50F72ED3390

Q37197199-46D7E032-5B34-48D6-BBDF-1775C967EC93

Q37197199-47390D45-1A75-49D0-B3AA-1DF3C728BC00

P304

Q37197199-05E913C4-2223-4291-BC12-BA1653ADA992

P31

Q37197199-65115BCC-CC31-4FE9-8D9C-F05999C7EFA1

P356

Q37197199-39717762-3DF4-471C-92BF-3713D92F4677

P433

Q37197199-A1A7CE4E-297C-415C-B39E-476002338BE7

P478

Q37197199-A27582D8-D593-40A7-8644-2AD6F4AA8E6D

P50

Q37197199-27BC79A0-F03E-4164-8EF2-8500F41B1187

Q37197199-55533077-F85F-4D7B-B0EA-2620B365266D

P577

Q37197199-40E68BCC-5B7E-42EF-AAA1-419A309A5BEC

P698

Q37197199-F620F07F-CE35-4F5F-BC40-375DE70AE7FB

P921

Q37197199-3EE2AE82-362A-4CE1-9172-8E3BEC0296D0

Q37197199-6BFE5126-21D1-4303-854B-0C7403D19774

P932

Q37197199-7E6DC279-50AB-4C94-BE22-72CF0A95D275

P356

1756285616659411

P1433

Therapeutic advances in neurological disorders

P1476

Novel oral anticoagulants for ...... emia: a network meta-analysis.

@en

P2093

Agathi-Rosa Vrettou

http://www.w3.org/2001/XMLSchema#string

Alexandra Frogoudaki

http://www.w3.org/2001/XMLSchema#string

Andrei V Alexandrov

http://www.w3.org/2001/XMLSchema#string

Angeliki Filippatou

http://www.w3.org/2001/XMLSchema#string

Anne W Alexandrov

http://www.w3.org/2001/XMLSchema#string

Apostolos Safouris

http://www.w3.org/2001/XMLSchema#string

Aristeidis H Katsanos

http://www.w3.org/2001/XMLSchema#string

Dimitris Mavridis

http://www.w3.org/2001/XMLSchema#string

Georgios Tsivgoulis

http://www.w3.org/2001/XMLSchema#string

John Ellul

http://www.w3.org/2001/XMLSchema#string

P2860

Guidelines for the Prevention of Stroke in Patients With Stroke and Transient Ischemic Attack: A Guideline for Healthcare Professionals From the American Heart Association/American Stroke Association

Predicting the extent of heterogeneity in meta-analysis, using empirical data from the Cochrane Database of Systematic Reviews

The Cochrane Collaboration's tool for assessing risk of bias in randomised trials

The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration

Meta-analysis in clinical trials

Critical appraisal of network meta-analyses evaluating the efficacy and safety of new oral anticoagulants in atrial fibrillation stroke prevention trials

Dabigatran versus warfarin in patients with atrial fibrillation

Rivaroxaban versus warfarin in nonvalvular atrial fibrillation

Apixaban versus warfarin in patients with atrial fibrillation

GRADE guidelines: 4. Rating the quality of evidence--study limitations (risk of bias)

P304

359-368

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1177/1756285616659411

http://www.w3.org/2001/XMLSchema#string

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

9

http://www.w3.org/2001/XMLSchema#string

P50

Ignatios Ikonomidis

Theodoros Karapanayiotides

P577

2016-07-20T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27582891

http://www.w3.org/2001/XMLSchema#string

P921

cerebral infarction

anticoagulation

P932

4994786

http://www.w3.org/2001/XMLSchema#string